JCVI has now issued updated advice in relation to COVID-19 vaccination of children and young people. The full JCVI statement can be found here at https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-and-young-people/jcvi-statement-on-covid-19- vaccination-of-children-and-young-people-22-december-2021

Primary vaccination in children aged 5 to 11 years

JCVI have now recommended that children aged five to 11 years in a clinical risk group (as defined in the Green Book); or children who are a household contact of someone who is immunosuppressed (as defined in the Green Book), should be offered two 10 micrograms doses of the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) with an interval of 8 weeks between the first and second doses. The minimum interval between any vaccine dose and recent COVID-19 infection should be four weeks.

Booster vaccinations in persons aged 12 to 17 years.

JCVI have also advised that the following cohorts of children and young people should be offered a booster dose of 30 micrograms Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) no sooner than 3 months after completion of their primary course:

I. All children and young people aged 16 to 17 years;

II. Children and young people aged 12 to 15 who are in a clinical risk group or who are a household contact of someone who is
immunosuppressed; and

III. Children and young people aged 12 to 17 years who are severely immunocompromised and who have had a third primary dose

doh-hss-md-89-2021